Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Suppression of Glucosylceramide Synthase Reverses Drug Resistance in Cancer Cells Harbor Homozygous p53 Mutants
Md Saqline Mostaq, Mohammad N Amin, Amanda Raphael, et al.
Molecular Cancer
|
June 15, 2010
Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling
Yong-Yu Liu, Vineet Gupta, Gauri A Patwardhan, et al.
FASEB Bioadvances
|
November 18, 2020
Gb3-cSrc complex in glycosphingolipid-enriched microdomains contributes to the expression of p53 mutant protein and cancer drug resistance via β-catenin-activated RNA methylation
Kartik R Roy, Mohammad B Uddin, Sagor C Roy, et al.
International Journal of Molecular Sciences
|
April 14, 2026
Suppression of Glucosylceramide Synthase Reverses Drug Resistance in Cancer Cells Harboring Homozygous p53 Mutants
Md Saqline Mostaq, Mohammad N Amin, Amanda Raphael, et al.
Biochemical Pharmacology
|
December 23, 2018
An N<sup>6</sup>-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells
Mohammad B Uddin, Kartik R Roy, Salman B Hosain, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
December 5, 2008
In vivo survivors of transformed mouse ovarian surface epithelial cells display diverse phenotypes for gene expression and tumorigenicity
Xiao-Lin Li, Dong-Qing Zhang, David Wang, et al.
Molecular Cancer Therapeutics
|
May 14, 2004
Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy
Valerie Gouazé, Jing Y Yu, Richard J Bleicher, et al.
Biochemical Pharmacology
|
April 14, 2010
Metabolism of short-chain ceramide by human cancer cells--implications for therapeutic approaches
Jacqueline V Chapman, Valérie Gouazé-Andersson, Maria C Messner, et al.
Plos One
|
September 11, 2009
A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosis
Gauri A Patwardhan, Qian-Jin Zhang, Dongmei Yin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 5, 2008
A role for ceramide in driving cancer cell resistance to doxorubicin
Yong-Yu Liu, Jing Yuan Yu, Dongmei Yin, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Suppression of Glucosylceramide Synthase Reverses Drug Resistance in Cancer Cells Harbor Homozygous p53 Mutants
Md Saqline Mostaq, Mohammad N Amin, Amanda Raphael, et al.
Molecular Cancer
|
June 15, 2010
Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling
Yong-Yu Liu, Vineet Gupta, Gauri A Patwardhan, et al.
FASEB Bioadvances
|
November 18, 2020
Gb3-cSrc complex in glycosphingolipid-enriched microdomains contributes to the expression of p53 mutant protein and cancer drug resistance via β-catenin-activated RNA methylation
Kartik R Roy, Mohammad B Uddin, Sagor C Roy, et al.
International Journal of Molecular Sciences
|
April 14, 2026
Suppression of Glucosylceramide Synthase Reverses Drug Resistance in Cancer Cells Harboring Homozygous p53 Mutants
Md Saqline Mostaq, Mohammad N Amin, Amanda Raphael, et al.
Biochemical Pharmacology
|
December 23, 2018
An N<sup>6</sup>-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells
Mohammad B Uddin, Kartik R Roy, Salman B Hosain, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
December 5, 2008
In vivo survivors of transformed mouse ovarian surface epithelial cells display diverse phenotypes for gene expression and tumorigenicity
Xiao-Lin Li, Dong-Qing Zhang, David Wang, et al.
Molecular Cancer Therapeutics
|
May 14, 2004
Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy
Valerie Gouazé, Jing Y Yu, Richard J Bleicher, et al.
Biochemical Pharmacology
|
April 14, 2010
Metabolism of short-chain ceramide by human cancer cells--implications for therapeutic approaches
Jacqueline V Chapman, Valérie Gouazé-Andersson, Maria C Messner, et al.
Plos One
|
September 11, 2009
A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosis
Gauri A Patwardhan, Qian-Jin Zhang, Dongmei Yin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 5, 2008
A role for ceramide in driving cancer cell resistance to doxorubicin
Yong-Yu Liu, Jing Yuan Yu, Dongmei Yin, et al.
Page
of 7